Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
24 Nov 2023, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Rifampicine
5596354
GEM/2023/B/4208852
Two Packet Bid
Title1,Title2,Title3,Title4,Title5
10 days
Ladakh; Leh Ladakh
Total value wise evaluation
BOQ
6 documents required · 6 mandatory
1 yrs
₹3
50%
Exempted
24 Nov 2023
14 Nov 2023
24 Nov 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | TAB INH 300MG | 4,000 | pieces | CHUNIT LADOL 194101,District TB Office, Leh UT Ladakh | 10 |
| 2 | Title2 | TAB INH 300MG | 4,000 | pieces | CHUNIT LADOL 194101,District TB Office, Leh UT Ladakh | 10 |
| 3 | Title3 | TAB RIFAMPICIN 450MG | 1,000 | pieces | CHUNIT LADOL 194101,District TB Office, Leh UT Ladakh | 10 |
| 4 | Title4 | TAB RIFAMPICIN 450MG | 1,500 | pieces | CHUNIT LADOL 194101,District TB Office, Leh UT Ladakh | 10 |
| 5 | Title5 | TAB PYRAZINAMIDE 500MG | 3,000 | pieces | CHUNIT LADOL 194101,District TB Office, Leh UT Ladakh | 10 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5596354.pdf
GEM_BID
whatsapp_image_2023-09-22_at_10-35-25_2023-09-28-09_2023-11-14-15-11-22_c3731d73a901033550b29583071cd4d3.pdf
BOQ
boq_item_sample_file_-12_2023-09-28-09-37-27_bf289f_2023-11-14-15-11-22_6c0d7cf923dc9910a06b24859f153e85.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .